Lack of Effector Cell Function and Altered Tetramer Binding of Tumor-Infiltrating Lymphocytes

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Immunology

• Publication date

  2002-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.169.10.5522PMID 12421928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Powered by the California Digital Library University of California ANIMALS BEARING MALIGNANT GRAFTS REJECT NORMAL GRAFTS THAT EXPRESS THROUGH GENE TRANSFER THE SAME ANTIGEN

  2003cited by this paper
• A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling

  2002cited by this paper
• Escaping High Viral Load Exhaustion

  2002cited by this paper
• Escaping High Viral Load Exhaustion: CD8 Cells with Altered Tetramer Binding in Chronic Hepatitis B Virus Infection

  2002cited by this paper
• Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective “Arming” of Tumor Antigen-Specific CTL1

  2001cited by this paper
• Role of TGF-beta in immune-evasion of cancer.

  2001cited by this paper
• Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

  2001cited by this paper
• Malignant glioma biology: Role for TGF‐β in growth, motility, angiogenesis, and immune escape

  2001cited by this paper
• CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis

  2001cited by this paper
• Immunity against solid tumors?

  2001cited by this paper
• Cutting Edge: Lipid Raft Integrity Affects the Efficiency of MHC Class I Tetramer Binding and Cell Surface TCR Arrangement on CD8+ T Cells1

  2001cited by this paper
• Antiviral Cd8+ T Cell Responses in Neonatal Mice

  2001cited by this paper
• Discrepancy between ELISPOT IFN-γ secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

  2001cited by this paper
• Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

  2001cited by this paper
• Role of TGF‐β in immune‐evasion of cancer

  2001cited by this paper
• Cutting Edge: Detection of Antigen-Specific CD4+ T Cells by HLA-DR1 Oligomers Is Dependent on the T Cell Activation State1

  2001cited by this paper
• Crucial Role of TNF-α in CD8 T Cell-Mediated Elimination of 3LL-A9 Lewis Lung Carcinoma Cells In Vivo1

  2000cited by this paper
• Incomplete Cd8+ T Lymphocyte Differentiation as a Mechanism for Subdominant Cytotoxic T Lymphocyte Responses to a Viral Antigen

  2000cited by this paper
• High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals

  1999cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions

  1999cited by this paper
• CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.

  1999cited by this paper
• Immune surveillance against a solid tumor fails because of immunological ignorance.

  1999cited by this paper
• Dendritic Cells Efficiently Induce Protective Antiviral Immunity

  1998cited by this paper
• Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology

  1998cited by this paper
• Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.

  1998cited by this paper
• Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

  1998cited by this paper
• Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

  1998cited by this paper
• Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors.

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy

  1997cited by this paper
• TAP off--tumors on.

  1997cited by this paper
• Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.

  1996cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• Fibroblasts as efficient antigen-presenting cells in lymphoid organs.

  1995cited by this paper
• Alterations in the signal‐transducing molecules of T cells and nk cells in colorectal tumor‐infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease

  1995cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper
• [Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates]

  1993cited by this paper
• Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.

  1992cited by this paper
• Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

  1992cited by this paper
• Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.

  1991cited by this paper
• Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen

  1990cited by this paper
• Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo

  1990cited by this paper
• Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.

  1989cited by this paper
• Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

  1989cited by this paper
• T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta.

  1987cited by this paper
• Concomitant tumor immunity and the resistance to a second tumor challenge.

  1983cited by this paper

• Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy

  2024cites this paper
• The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity

  2024cites this paper
• Targeting Macrophage Polarization for Reinstating Homeostasis following Tissue Damage

  2024cites this paper
• Macrophages and Metabolic Reprograming in the Tumor Microenvironment

  2022cites this paper
• Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis

  2021cites this paper
• Antigen Cross-Presentation by Macrophages

  2020cites this paper
• Tumor Lactic Acidosis: Protecting Tumor by Inhibiting Cytotoxic Activity Through Motility Arrest and Bioenergetic Silencing

  2020cites this paper
• PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor

  2020cites this paper
• PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and tumor target cells within the tumor

  2018influential citation
• Science Journals — AAAS

  2016cites this paper
• Suppression of T cell responses in the tumor microenvironment.

  2015influential citation
• Differences in TCR-Vβ Repertoire and Effector Phenotype between Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes Increase with Age

  2014cites this paper
• Endogenous tumor-reactive CD8+ T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth

  2013cites this paper
• Mechanisms of Metastatic Tumor Dormancy

  2013cites this paper
• Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity

  2013cites this paper
• Lysophosphatidic Acid Inhibits CD8 T-cell Activation and Control of Tumor Progression

  2013cites this paper
• Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth

  2013cites this paper
• Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode

  2013cites this paper
• Melanoma-Associated Suppression of the Dendritic Cell Lines DC2.4 and Jawsii

  2012cites this paper
• Suppression of the maturation and activation of the dendritic cell line DC2.4 by melanoma-derived factors.

  2012cites this paper
• Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation

  2012cites this paper
• The immune system: endogenous anticancer mechanism.

  2012cites this paper
• Concepts and ways to amplify the antitumor immune response.

  2011cites this paper
• Combining Cancer Vaccines with Conventional Therapies

  2011cites this paper
• lymphoma by an idiotype-specific peptide binder In vivo targeting and growth inhibition of the A20 murine B-cell

  2011cites this paper
• Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication

  2011cites this paper
• Etude de deux chimiokines CXCL12/SDF-1 et fractalkine (FKN)/CX3CL1 dans le cancer épithélial des ovaires

  2011cites this paper
• Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope

  2011influential citation
• In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder.

  2010cites this paper
• Tracking total polyclonal CD8 T cell responses in inbred and outbred hosts after infection

  2010cites this paper
• Die immunsuppressive Wirkung von Tumormetaboliten auf humane T-Zellen

  2010cites this paper
• Antigen specific memory T cells and their putative need for the generation of sustained anti-tumor responses.

  2010cites this paper
• Cancer immunotherapy targeting T cell costimulatory molecules

  2010cites this paper
• Human CD8+ T Regulatory cells with low avidity TcR specific for minor Histocompatibility antigens

  2009cites this paper
• Toward general prophylactic cancer vaccination

  2009cites this paper
• Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE21

  2009cites this paper
• Cancer Cell-Derived PGE CellsRecruiting Myeloid-Derived Suppressor Fas Signal Promotes Lung Cancer Growth

  2009cites this paper
• Strategies and challenges in eliciting immunity to melanoma

  2008cites this paper
• The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.

  2008cites this paper
• TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction

  2008cites this paper
• Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.

  2008cites this paper
• Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens.

  2008cites this paper
• Abnormal variation of the immune response as related to cancer

  2008cites this paper
• Virus‐based immunotherapy of cancer: what do we know and where are we going?

  2007cites this paper
• Immune surveillance of tumors.

  2007cites this paper
• Activated B cells mediate efficient expansion of rare antigen-specific T cells.

  2007cites this paper
• Epitope Immunization against an Immunorecessive Progression following Secondary DiseaseAdvanced-Stage Tumors and Delay of T Cells in + Accumulation of CD 8

  2006cites this paper
• Solid tumors “melt” from the inside after successful CD8 T cell attack

  2006cites this paper
• Accumulation of CD8+ T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope1

  2006cites this paper
• Serotype Cross-Reactive CD8+ T Cell Response to Heterologous Secondary Dengue Virus Infections in Humans: a Dissertation

  2006cites this paper
• Tumor-Draining Lymph Nodes Antigen-Specific CD 8 T Cells in Incomplete Differentiation of and

  2006cites this paper
• HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD‐1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma

  2006cites this paper
• Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes1

  2006cites this paper
• Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells1

  2005cites this paper
• Analysis of T-Cell Clonality Pattern in Tumor Samples of Breast Cancer Patients

  2005cites this paper
• Cancer immunotherapy based on killing of Salmonella-infected tumor cells.

  2005cites this paper
• Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.

  2005cites this paper
• Cytolysis toResponse to Antigen but Lack Granzyme B Signal 3 Tolerant CD 8 T Cells Degranulate in

  2005cites this paper
• The functional avidity of virus‐specific CD8+ T cells is down‐modulated in Borna disease virus‐induced immunopathology of the central nervous system

  2005cites this paper
• Analysis of T-cell clonality pattern in tumor samples of breast cancer patients.

  2005cites this paper
• Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1

  2005cites this paper
• Clonal dynamics of tumor‐infiltrating lymphocytes

  2005cites this paper
• Antitumor effect of double immunization of mice with mucin 1 and its coding DNA.

  2005cites this paper
• Immune surveillance and anti-tumor immune responses: an anatomical perspective.

  2005cites this paper
• Transient Loss of MHC Class I Tetramer Binding after CD8+ T Cell Activation Reflects Altered T Cell Effector Function1

  2005influential citation
• Tracking memory CD4 T cells in vivo: requirements for the generation, survival and re-activation of memory cells

  2005cites this paper
• Loss of CD 8 and TCR binding to Class I MHC ligands following T cell activation

  2005cites this paper
• Treatment options in chronic myeloid leukemia: imatinib vs interferon

  2004cites this paper
• Effector and regulatory T cells derived from the same T cell clone differ in MHC class II‐peptide multimer binding

  2004cites this paper
• Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors

  2004cites this paper
• Prostate Tumor Microenvironment Alters Immune Cells and Prevents Long-Term Survival in an Orthotopic Mouse Model Following flt3-Ligand/CD40-Ligand Immunotherapy

  2004cites this paper
• Novel peptide‐based vaccines efficiently prime murine “help”‐independent CD8+ T cell responses in the liver

  2004cites this paper
• CpG-matured Murine Plasmacytoid Dendritic Cells Are Capable of In Vivo Priming of Functional CD8 T Cell Responses to Endogenous but Not Exogenous Antigens

  2004cites this paper
• A Transgenic Mouse Model Genetically Tags All Activated CD8 T Cells 1

  2003cites this paper
• Vasculature: A Novel Mechanism for IL-2 Tumor Cells and Tumor-Associated T Cells That Mediate Destruction of + CD8IL-2 Intratumoral Immunotherapy Enhances

  2003cites this paper
• IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells That Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: A Novel Mechanism for IL-2 1

  2003cites this paper
• Heterogeneity of CD4(+) and CD8(+) T cells.

  2003cites this paper
• All Activated CD8 T Cells A Transgenic Mouse Model Genetically Tags

  2003cites this paper